ID

20131

Beschrijving

5-Azacytidine (Azacytidine; Vidaza) in Chronic Lymphocytic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00413478

Link

https://clinicaltrials.gov/show/NCT00413478

Trefwoorden

Versies (1)
  1. 08-02-17 08-02-17 -
Geüploaded op

8 februari 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Chronic Lymphocytic Leukemia NCT00413478

Engels

Eligibility Chronic Lymphocytic Leukemia NCT00413478

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. patients with chronic lymphocytic leukemia (cll), prolymphocytic leukemia, richter's transformation or t-pll who have previously been treated with fludarabine or another regime are eligible.
Beschrijving

Chronic Lymphocytic Leukemia | Prolymphocytic Leukemia | Richter's syndrome | T-Cell Prolymphocytic Leukemia | fludarabine | Patients Treated

Datatype

boolean

Alias
UMLS CUI [1]
C0023434
UMLS CUI [2]
C0023486
UMLS CUI [3]
C0349631
UMLS CUI [4]
C2363142
UMLS CUI [5]
C0059985
UMLS CUI [6,1]
C0030705
UMLS CUI [6,2]
C1522326
2. patients with histologically or cytologically confirmed richter's transformation.
Beschrijving

Richter's syndrome

Datatype

boolean

Alias
UMLS CUI [1]
C0349631
3. serum glutamic-oxaloacetic transaminase (sgot) or serum glutamic-pyruvic transaminase (sgpt) less than x 2 normal levels.
Beschrijving

Aspartate aminotransferase measurement | Alanine aminotransferase measurement

Datatype

boolean

Alias
UMLS CUI [1]
C0201899
UMLS CUI [2]
C0201836
4. women of childbearing potential who have a negative pregnancy test prior to azacytidine treatment.
Beschrijving

Childbearing Potential Pregnancy test negative | Azacitidine

Datatype

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0427780
UMLS CUI [2]
C0004475
5. women of childbearing potential who agreed not to become pregnant and men agreed not to father a child while on azacytidine treatment.
Beschrijving

Childbearing Potential Agreement Pregnancy Absent | Gender Agreement Reproduction Absent | Azacitidine

Datatype

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0680240
UMLS CUI [1,3]
C0032961
UMLS CUI [1,4]
C0332197
UMLS CUI [2,1]
C0079399
UMLS CUI [2,2]
C0680240
UMLS CUI [2,3]
C0035150
UMLS CUI [2,4]
C0332197
UMLS CUI [3]
C0004475
6. performance 0-2 (ecog). adequate liver function (bilirubin of less than2mg/dl) and renal function (creatinine less than 2mg/dl). adequate cardiac functions (nyha cardiac iii-iv excluded).
Beschrijving

ECOG performance status | Liver function | Serum total bilirubin measurement | Renal function | Creatinine measurement, serum | Cardiac function | Heart Disease New York Heart Association Classification Exclusion

Datatype

boolean

Alias
UMLS CUI [1]
C1520224
UMLS CUI [2]
C0232741
UMLS CUI [3]
C1278039
UMLS CUI [4]
C0232804
UMLS CUI [5]
C0201976
UMLS CUI [6]
C0232164
UMLS CUI [7,1]
C0018799
UMLS CUI [7,2]
C1275491
UMLS CUI [7,3]
C2828389
7. signed informed consent.
Beschrijving

Informed Consent

Datatype

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. breast feeding or pregnant females. patients of (male and female) childbearing potential should practice effective methods of contraception; otherwise, they will be excluded. should a woman become pregnant or suspect she is pregnant while participating in this study, she should inform her treating physician immediately.
Beschrijving

Pregnancy | Breast Feeding | Childbearing Potential Contraceptive methods

Datatype

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3,1]
C3831118
UMLS CUI [3,2]
C0700589
2. known or suspected hypersensitivity to azacytidine or mannitol.
Beschrijving

Hypersensitivity Azacitidine | Mannitol allergy | Hypersensitivity Suspected Azacitidine | Mannitol allergy Suspected

Datatype

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0004475
UMLS CUI [2]
C0571922
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0750491
UMLS CUI [3,3]
C0004475
UMLS CUI [4,1]
C0571922
UMLS CUI [4,2]
C0750491
3. active and uncontrolled infections.
Beschrijving

Communicable Diseases Uncontrolled

Datatype

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0205318
4. patients with advanced malignant hepatic tumors.
Beschrijving

Malignant neoplasm of liver Advanced

Datatype

boolean

Alias
UMLS CUI [1,1]
C0345904
UMLS CUI [1,2]
C0205179
5. uncontrolled intercurrent illness including, but not limited to, symptomatic congestive heart failure, unstable angina pectoris, or psychiatric illness/social situations that would limit compliance with study requirements.
Beschrijving

Illness Uncontrolled | Symptomatic congestive heart failure | Angina, Unstable | Mental disorder Protocol Compliance Limited | Social situation Protocol Compliance Limited

Datatype

boolean

Alias
UMLS CUI [1,1]
C0221423
UMLS CUI [1,2]
C0205318
UMLS CUI [2]
C0742758
UMLS CUI [3]
C0002965
UMLS CUI [4,1]
C0004936
UMLS CUI [4,2]
C0525058
UMLS CUI [4,3]
C0439801
UMLS CUI [5,1]
C0748872
UMLS CUI [5,2]
C0525058
UMLS CUI [5,3]
C0439801
Terug naar het begin van de pagina

Similar models

Eligibility Chronic Lymphocytic Leukemia NCT00413478

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Chronic Lymphocytic Leukemia | Prolymphocytic Leukemia | Richter's syndrome | T-Cell Prolymphocytic Leukemia | fludarabine | Patients Treated
Item
1. patients with chronic lymphocytic leukemia (cll), prolymphocytic leukemia, richter's transformation or t-pll who have previously been treated with fludarabine or another regime are eligible.
boolean
C0023434 (UMLS CUI [1])
C0023486 (UMLS CUI [2])
C0349631 (UMLS CUI [3])
C2363142 (UMLS CUI [4])
C0059985 (UMLS CUI [5])
C0030705 (UMLS CUI [6,1])
C1522326 (UMLS CUI [6,2])
Richter's syndrome
Item
2. patients with histologically or cytologically confirmed richter's transformation.
boolean
C0349631 (UMLS CUI [1])
Aspartate aminotransferase measurement | Alanine aminotransferase measurement
Item
3. serum glutamic-oxaloacetic transaminase (sgot) or serum glutamic-pyruvic transaminase (sgpt) less than x 2 normal levels.
boolean
C0201899 (UMLS CUI [1])
C0201836 (UMLS CUI [2])
Childbearing Potential Pregnancy test negative | Azacitidine
Item
4. women of childbearing potential who have a negative pregnancy test prior to azacytidine treatment.
boolean
C3831118 (UMLS CUI [1,1])
C0427780 (UMLS CUI [1,2])
C0004475 (UMLS CUI [2])
Childbearing Potential Agreement Pregnancy Absent | Gender Agreement Reproduction Absent | Azacitidine
Item
5. women of childbearing potential who agreed not to become pregnant and men agreed not to father a child while on azacytidine treatment.
boolean
C3831118 (UMLS CUI [1,1])
C0680240 (UMLS CUI [1,2])
C0032961 (UMLS CUI [1,3])
C0332197 (UMLS CUI [1,4])
C0079399 (UMLS CUI [2,1])
C0680240 (UMLS CUI [2,2])
C0035150 (UMLS CUI [2,3])
C0332197 (UMLS CUI [2,4])
C0004475 (UMLS CUI [3])
ECOG performance status | Liver function | Serum total bilirubin measurement | Renal function | Creatinine measurement, serum | Cardiac function | Heart Disease New York Heart Association Classification Exclusion
Item
6. performance 0-2 (ecog). adequate liver function (bilirubin of less than2mg/dl) and renal function (creatinine less than 2mg/dl). adequate cardiac functions (nyha cardiac iii-iv excluded).
boolean
C1520224 (UMLS CUI [1])
C0232741 (UMLS CUI [2])
C1278039 (UMLS CUI [3])
C0232804 (UMLS CUI [4])
C0201976 (UMLS CUI [5])
C0232164 (UMLS CUI [6])
C0018799 (UMLS CUI [7,1])
C1275491 (UMLS CUI [7,2])
C2828389 (UMLS CUI [7,3])
Informed Consent
Item
7. signed informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Breast Feeding | Childbearing Potential Contraceptive methods
Item
1. breast feeding or pregnant females. patients of (male and female) childbearing potential should practice effective methods of contraception; otherwise, they will be excluded. should a woman become pregnant or suspect she is pregnant while participating in this study, she should inform her treating physician immediately.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C3831118 (UMLS CUI [3,1])
C0700589 (UMLS CUI [3,2])
Hypersensitivity Azacitidine | Mannitol allergy | Hypersensitivity Suspected Azacitidine | Mannitol allergy Suspected
Item
2. known or suspected hypersensitivity to azacytidine or mannitol.
boolean
C0020517 (UMLS CUI [1,1])
C0004475 (UMLS CUI [1,2])
C0571922 (UMLS CUI [2])
C0020517 (UMLS CUI [3,1])
C0750491 (UMLS CUI [3,2])
C0004475 (UMLS CUI [3,3])
C0571922 (UMLS CUI [4,1])
C0750491 (UMLS CUI [4,2])
Communicable Diseases Uncontrolled
Item
3. active and uncontrolled infections.
boolean
C0009450 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
Malignant neoplasm of liver Advanced
Item
4. patients with advanced malignant hepatic tumors.
boolean
C0345904 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
Illness Uncontrolled | Symptomatic congestive heart failure | Angina, Unstable | Mental disorder Protocol Compliance Limited | Social situation Protocol Compliance Limited
Item
5. uncontrolled intercurrent illness including, but not limited to, symptomatic congestive heart failure, unstable angina pectoris, or psychiatric illness/social situations that would limit compliance with study requirements.
boolean
C0221423 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0742758 (UMLS CUI [2])
C0002965 (UMLS CUI [3])
C0004936 (UMLS CUI [4,1])
C0525058 (UMLS CUI [4,2])
C0439801 (UMLS CUI [4,3])
C0748872 (UMLS CUI [5,1])
C0525058 (UMLS CUI [5,2])
C0439801 (UMLS CUI [5,3])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial